Aspen Aerogels (NYSE:ASPN – Get Free Report) issued its earnings results on Thursday. The construction company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.05), Zacks reports. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The company had revenue of $73.02 million during the quarter, compared to analyst estimates of $73.42 million. During the same period in the prior year, the business earned ($0.17) earnings per share. Aspen Aerogels’s quarterly revenue was down 37.8% on a year-over-year basis. Aspen Aerogels updated its FY 2025 guidance to -4.150–4.050 EPS.
Aspen Aerogels Trading Down 8.4%
Aspen Aerogels stock traded down $0.35 during mid-day trading on Friday, hitting $3.77. 2,326,502 shares of the company’s stock were exchanged, compared to its average volume of 2,021,087. The company’s 50 day simple moving average is $7.35 and its 200-day simple moving average is $6.77. Aspen Aerogels has a fifty-two week low of $3.70 and a fifty-two week high of $17.56. The firm has a market capitalization of $310.09 million, a P/E ratio of -1.00 and a beta of 2.85. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34.
Insider Transactions at Aspen Aerogels
In other news, CAO Santhosh P. Daniel sold 4,410 shares of the stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total value of $32,237.10. Following the completion of the sale, the chief accounting officer owned 19,879 shares of the company’s stock, valued at approximately $145,315.49. This represents a 18.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 4.30% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Aspen Aerogels
Analyst Upgrades and Downgrades
Several research firms recently commented on ASPN. Canaccord Genuity Group lowered their target price on Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Aspen Aerogels in a report on Wednesday, October 8th. Finally, Barclays dropped their price target on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a research note on Friday. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $13.50.
Get Our Latest Research Report on Aspen Aerogels
Aspen Aerogels Company Profile
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Recommended Stories
- Five stocks we like better than Aspen Aerogels
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- SoundHound Beat Earnings & Dropped—Here’s What Wall Street Missed
- Why Are These Companies Considered Blue Chips?
- AI Trade Over? Datadog Results Say It’s Gaining Momentum
- Short Selling – The Pros and Cons
- Getting Defensive: 3 Dividend Payers Reporting Strong Q3 Earnings
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
